Share This

Topics Comments
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
China Traditional Chinese Medicine Holdings Co. Limited 2014-04-24T09:44 財經茄呢啡 中國中藥集團（570）計劃在佛山興建集研發及生產於一身的總部，另已投得貴州330畝土地建設骨科中藥產地，兩者皆料在2016年落成。近期則與上海醫藥工業研究院開發三項中藥新藥產品和五項首仿制藥，集中投入心腦血管等老年性疾病用藥研發。
China Traditional Chinese Medicine Holdings Co. Limited 2014-04-24T09:43 財經茄呢啡 中國中藥集團（570）目前已共擁500多項中西藥品種和規格生產批文，其中包括60多個獨家生產品種和規格，並有26個獨家產品被列入國家基本醫療保險用藥目錄，包括骨骼、鼻炎、風濕及腫瘤療藥等。集團現時在內地共有11處產地，擁50多條GMP認證產線，年產顆粒劑8億包、片劑55億片、膠囊劑30億粒、藥酒1,400萬瓶、抗生素及腫瘤藥粉針1億支等。
China Traditional Chinese Medicine Holdings Co. Limited 2014-04-24T09:43 財經茄呢啡 中國中藥集團（570）去年由國務院旗下的國藥集團購入57%絕對控股權，其後再向原大股東及復星醫藥（2196）購入同濟堂權益。同濟堂業績去年11月才正式入賬，將令中國中藥今年盈利大增。
China Traditional Chinese Medicine Holdings Co. Limited 2014-01-16T09:40 財經茄呢啡 中國中藥（570）前身是盈天醫藥，去年被國藥集團收歸旗下改名，並成功收購同濟堂。前身盈天以開發呼吸及鼻部用藥、心腦血管藥及風濕骨傷藥為主，而同濟堂則以骨科中藥著名，通過收購，中國中藥可快速進軍骨科藥物市場，打造成中藥平台，估計日後會陸續有收購進行，而每宗收購都會成為股價上升催化劑。中國中藥料可破關升向4元，可於現價買入，跌破3.35元止蝕。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.